AI and multiomics reveal how gut bacteria trigger colon cancer
Over the past two decades, high‑throughput sequencing has dramatically expanded our understanding of the gut microbiome’s composition. However,…
New spatial map reveals treatment vulnerabilities in bladder cancer
Researchers at The University of Texas MD Anderson Cancer Center have developed a spatial map of muscle-invasive bladder…
New biomarker predicts gastric cancer outcomes from CT scans
Researchers at the State University of Campinas (UNICAMP) in São Paulo, Brazil, have identified a new biomarker that…
Engineered silica nanoparticles destroy prostate tumors in preclinical study
Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while enhancing anti-tumor immunity,…
Researchers identify vulnerabilities shared by surviving cancer cells
Cancer drugs can shrink fast-growing tumors. But sometimes a few tumor cells survive. These “persister” cells seed new…
New genetic driver found for rare small intestinal cancers
A signaling system known as the Wnt pathway plays a central role in how cells in the intestine…
Circadian clock protein BMAL1 enhances inflammatory responses in immune cells
Daily life is shaped by the solar day, influencing when we wake up, eat, work, and sleep. Inside…
Viral DNA blood test accurately gauges post-surgery cancer recovery success
A new study by investigators from Mass General Brigham Cancer Institute found that an ultrasensitive blood test called…
Scientists reveal how cGAS-STING fuels brain inflammation and neurodegeneration
A major immune pathway once known for detecting DNA damage is now being linked to brain aging, glial…
New meningioma atlas uncovers clues to tumor aggressiveness
One of the most detailed maps to date of meningioma – the most common brain tumor in adults – reveals…
Advanced MRI scans predict chronic kidney disease in patients undergoing nephrectomy
An investigator at the Icahn School of Medicine at Mount Sinai has received international recognition for innovative imaging…
Study identifies new therapeutic candidate for KRAS-driven pancreatic cancer
A new research paper was published in Volume 17 of Oncotarget on June 3, 2026, titled “The anticancer effects of PCAIs…